Skip to main content

GuidelinesRegulatory updates2026.11.22

Two Medical Devices Act amendments promulgated in September and October: online advertising monitoring, brokering ban, expenditure report exemption and national essential medical devices

Act No. 21949, promulgated on 15 September 2026, and Act No. 22105, promulgated on 20 October, have different effective dates for different articles. Requests for Korea Customs Service import declaration records and the expenditure report exemption for sellers are already in force; online labelling and advertising monitoring and the ban on brokering the sale or lease of unapproved medical devices take effect on 16 March 2027, and the national essential medical device system from 21 October 2027. Based on the amendment texts, this guide sets out the articles that change on each effective date and the points to watch by business type.

Key takeaway The two Medical Devices Act amendments promulgated in September and October do not take effect all at once. Article 32-3 of Act No. 21949 (requests for Korea Customs Service import declaration records) has been in force since 15 September 2026, and Article 18(5) of Act No. 22105 (expenditure report exemption) since 20 October. Online labelling and advertising monitoring and the ban on brokering the sale or lease of unapproved medical devices take effect on 16 March 2027, the national essential medical device system on 21 October 2027, and on 31 December 2027 the sales order article numbers each move down by one.

This article is based on the amendment texts, reasons for amendment and addenda of the two Acts, and the text of each version by effective date, obtained from the National Law Information Center on 9 November 2026. How to pick versions by effective date is in the guide to the structure of the Medical Devices Act and current versions, and the part effective 10 December is in the Act No. 21775 guide.

Arranged by effective date

Effective date Basis Content
15 September 2026 (in force) Proviso to Article 1 of the addenda to No. 21949 Article 32-3, requests to the Commissioner of the Korea Customs Service for import declaration records
20 October 2026 (in force) Proviso to Article 1 of the addenda to No. 22105 Article 18(5), expenditure report exemption for sellers and lessors
16 March 2027 Main text of No. 21949 Articles 24-2 to 24-5 on online labelling and advertising monitoring etc., deletion of Article 25-4, Article 26(8) brokering ban, Article 56(1) administrative fines
21 October 2027 Main text of No. 22105 Definition of national essential medical devices, stable supply base and council, additional work for the National Institute of Medical Device Safety Information
31 December 2027 Provisos in the addenda to both Acts Article numbers and cross-references of Articles 18 and 56 etc. of Act No. 21263 rearranged

Contents of Act Nos. 21949 and 22105 by effective date: 15 September 2026, 20 October 2026, 16 March 2027, 21 October 2027 and 31 December 2027

Already in force: import declaration record requests and the expenditure report exemption

Article 32-3. Where necessary to investigate the import, for the purpose of sale, lease, giving or use, of medical devices without import approval or certification or without notification, the Minister of Food and Drug Safety may ask the Commissioner of the Korea Customs Service for the import declaration records of medical devices declared for import under Article 241 of the Customs Act. The Commissioner must cooperate unless there is a justifiable reason. For documents at the customs clearance stage, see the import customs clearance guide.

Article 18(5). Article 18(4) applies Article 13-2 mutatis mutandis to sellers and lessors, requiring them to prepare an expenditure report on economic benefits etc. within three months after the end of each fiscal year, disclose it as prescribed by Ordinance of the Ministry of Health and Welfare, and keep it for five years. The new paragraph 5 provides that Article 13-2(1) does not apply mutatis mutandis to sellers and lessors that, in that fiscal year, did not sell or lease medical devices to medical institutions and did not provide economic benefits etc. to, or let them be obtained by, medical personnel, founders of medical institutions or medical institution staff. Both conditions must be met. Article 2 of the addenda provides that it applies from the expenditure report for the fiscal year that includes the effective date. For a company whose fiscal year runs from January to December, that means from the 2026 fiscal year. A seller that sells online only to consumers should keep a record of whether it meets both conditions, together with its records of customers for each fiscal year. Sales business notification in general is covered in the sales business notification guide.

16 March 2027: online labelling and advertising monitoring and the brokering ban

Article 24-2(1) allows the Minister of Food and Drug Safety to monitor whether medical device labelling and advertising using information and communications networks violates Article 24(1) or (2) or Article 26(7). Article 26(7) deals with labelling or advertising something that is not a medical device as if it had effects similar to a medical device. Because this provision is among the monitoring criteria, advertising for general products advertised like medical devices can also be checked.

Article Content
Article 24-2(2) Where a violation is found but the advertiser cannot be identified, request materials from an information and communications service provider (including its domestic agent) or a mail-order brokerage business operator, which must comply unless there is a justifiable reason
Article 24-2(3) Where a violation is clear, request measures to inform consumers, such as posting the fact of the violation
Article 24-3 Monitoring work may be entrusted to institutions or organisations prescribed by Presidential Decree
Article 24-5 Associations etc. whose members are manufacturers, importers, repairers, sellers or lessors may set and implement codes of conduct and self-regulation guidelines
Deletion of Article 25-4 The article under which self-regulatory review bodies monitored the advertising they had reviewed and submitted the results is deleted

If a platform fails without justifiable reason to comply with a request for materials, it is subject to an administrative fine of up to KRW 5 million under Article 56(1). The content, method and procedure of monitoring and the scope of materials to be submitted are left to Ordinance of the Prime Minister, so the lower-level rules need checking.

The new Article 26(8) provides that no one may broker the sale or lease of medical devices whose sale or lease is prohibited under paragraph 1, medical devices under the items of paragraph 2, or things whose sale or lease is prohibited under paragraph 7. A violation carries imprisonment of up to one year or a fine of up to KRW 10 million under Article 53-2, item 6. The Act does not define brokering separately. Businesses that link transactions without selling directly, such as intermediation, purchasing agency and affiliate links, should first check whether the items they handle are approved, certified or notified. Wording criteria for listing pages are in the advertising rules for product listings guide, and the boundary with general products is in the online seller wording guide.

21 October 2027: national essential medical devices

Article 2(5) defines national essential medical devices as medical devices that are essential to health care but for which there is no substitutable product or whose stable supply is difficult through market functions alone, so that an interruption of supply could cause serious harm to public health, and which the Minister of Health and Welfare and the Minister of Food and Drug Safety designate after consultation in the council.

Article Content
Article 43-7 The Minister of Health and Welfare and the Minister of Food and Drug Safety establish and implement comprehensive measures for stable supply, and support research and development and localisation etc.
Article 43-8(1) to (4) A national essential medical device stable supply council at MFDS, with up to 30 members including two chairs, and members recommended by industry and patient organisations etc.
Article 43-8(7) and (8) Requests to manufacturers and importers to cooperate in expanding production and imports, and to sellers, lessors and founders of medical institutions to cooperate in improving distribution
Article 43(1)8 to 8-4 Adds to the Institute's work surveys and analysis relating to designation, information collection, and analysis, evaluation and provision of the contents of production performance and supply record reports etc.

The council also deals with medical devices that are not designated but need stable supply for reasons prescribed by Ordinance of the Prime Minister, such as a temporary rise in demand. Its period of existence is set by Presidential Decree within five years. It is also worth noting that the annual performance reports and supply record reports are named in the Institute's analysis work. How to make performance reports is set out in the production, export and import performance report guide.

31 December 2027: articles whose numbers change

Act No. 21263 (promulgated 30 December 2025) deferred the amendments to Articles 18, 18-6 and 56 etc. until two years after promulgation. Because Act No. 22105 inserted Article 18(5) first in the meantime, in the version effective 31 December 2027 the ban on selling or leasing to medical institutions in a special relationship becomes Article 18(6), the report on that status becomes paragraph 7, and the numbering continues through to the transaction payment provision as paragraph 12. The administrative fine provisions are split earlier, on 16 March 2027, into Article 56(1) (up to KRW 5 million) and paragraph 2 (up to KRW 1 million) under the main text of Act No. 21949; in the version effective on this date, items on the report on medical institutions in a special relationship and on submitting materials under Article 18-6 are added to paragraph 2. If you have recorded article numbers in internal rules and contracts, change them as of this date.

Relationship with the legislative notice of 8 September

The order to submit materials (Article 32) and the general corrective order (Article 35-2) in the legislative notice introduced on 8 September are not in these two Acts. The Medical Devices Act history list on 9 November 2026 also showed no amendment promulgated after the two Acts. That proposal becomes law only after it is passed by the National Assembly and promulgated.

If you need to sort out in what order articles with different effective dates apply to your business type, write down your business type, sales channels and advertising channels and contact us. Clare Partners will separate what to do now from what to put into your 2027 schedule.

Legal sources: Act No. 21949 partially amending the Medical Devices Act (promulgated 15 September 2026) Articles 24-2 to 24-5, 25-4, 26(8), 32-3, 53-2 and 56, Article 1 of the addenda · Act No. 22105 partially amending the Medical Devices Act (promulgated 20 October 2026) Article 2(5), Article 18(5), Articles 42, 43, 43-7 and 43-8, Articles 1 and 2 of the addenda · Article 1 of the addenda to Act No. 21263 · Medical Devices Act current version (effective 20 October 2026) and Article 18 of the version effective 31 December 2027. Original texts and history checked: 2026-11-09.

Frequently asked questions

Q. Does a seller that does not sell to medical institutions still have to prepare an expenditure report?
Under Article 18(5), in force since 20 October 2026, Article 13-2(1) (preparation, disclosure and retention of expenditure reports) does not apply mutatis mutandis to sellers and lessors that, in the fiscal year concerned, did not sell or lease medical devices to medical institutions and did not provide economic benefits etc. to, or let them be obtained by, medical personnel, founders of medical institutions or medical institution staff. Under Article 2 of the addenda, it applies from the expenditure report for the fiscal year that includes the effective date.
Q. When does the ban on brokering the sale of unapproved medical devices start?
Article 26(8), newly added by Act No. 21949, takes effect on 16 March 2027. It prohibits anyone from brokering the sale or lease of medical devices etc. whose sale or lease without approval, certification or notification is prohibited, and a violation is subject to imprisonment of up to one year or a fine of up to KRW 10 million under Article 53-2, item 6.
Q. Can MFDS require an open market to provide advertiser information?
Yes, from 16 March 2027. Article 24-2(2) allows MFDS, where monitoring finds a violation but the advertiser cannot be identified, to request the necessary materials from an information and communications service provider or a mail-order brokerage business operator, which must comply unless there is a justifiable reason. Failure to comply is subject to an administrative fine of up to KRW 5 million under Article 56(1).
Q. If a device is designated a national essential medical device, does the manufacturer take on obligations?
Article 43-8(7), taking effect on 21 October 2027, allows the Minister of Food and Drug Safety to ask manufacturers or importers to cooperate in expanding production or imports with regard to matters discussed and coordinated in the council. It provides that administrative, financial and technical support may be given along with the request, and leaves the method and procedure for requests for cooperation to Presidential Decree.

Just send the product details.
We do the reviewing.

We pre-review device class, required pathway, and data readiness free of charge, and reply within 1 business day. No sign-up.